Skip to main content
. 2020 May 8;11:664. doi: 10.3389/fphar.2020.00664

Figure 2.

Figure 2

The relationship between erlotinib steady state trough plasma concentrations and CYP1A1rs1048943 (A), CYP1A2rs762551(B), rs2470890 (C), CYP2D6rs1065852 (D), CYP3A4rs2242480 (E), CYP3A5rs776746 (F).